ESC Professional Premium Access

Influence of novel risk markers on defibrillator implantation in hypertrophic cardiomyopathy

Congress Presentation

About the speaker

Mr William Procter

Barts Health Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

6 more presentations in this session

Atrial fibrillation concerning worse prognosis in patients with left ventricular noncompaction

Speaker: Doctor W. Xu (Beijing, CN)


Promise or peril : The ECG in HCM

Speaker: Doctor H. Cronin (Cork, IE)


New-onset atrial fibrillation diagnosed by cardiac implantable devices in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis

Speaker: Doctor V. Hurtado (Miami, US)


3 year outcomes of permanent pacemaker implantation after alcoholic septal ablation

Speaker: Doctor A. Grazina (Lisbon, PT)


Prognostic role of low QRS voltages in patients with cardiac amyloidosis

Speaker: Associate Professor F. Guerra (Ancona, IT)


Access the full session

Electrocardiography and cardiomyopathies

Speakers: Mr W. Procter, Doctor W. Xu, Doctor H. Cronin, Doctor V. Hurtado, Doctor A. Grazina...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb